Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01781455 · ClinicalTrials.gov registry record · Phase 1
A Study of BBI503 in Adult Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by Sumitomo Pharma America.
- Completed
- Registry status
- Phase 1
- Development phase
- 311
- Enrollment target
NCT01781455: Completed Phase 1 study, sponsored by Sumitomo Pharma America.
NCT01781455 is a Phase 1 study that has completed, run by Sumitomo Pharma America. The registered enrollment target is 311 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (418% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01781455, a Phase 1 study, has completed, sponsored by Sumitomo Pharma America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 311 participants
- Enrollment target
Study Summary
This is an open label, single arm dose escalation study of BBI503 in adult patients with advanced solid tumors.
Primary Outcome
Assessment of safety of BBI503 by reporting of adverse events and serious adverse events.
Interventions
- DRUG BBI503
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 311 participants |
| Start Date | 2012-02 |
| Est. Completion | 2020-06 |
| Phase | Phase 1 |
What the finished NCT01781455 record still lists
NCT01781455 is an interventional study that assigns participants to a tested intervention. The registered 311 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (418% higher).
The record links to 0 conditions, and to 1 intervention - of which BBI503 is the first listed.
NCT01781455 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01781455 about?
NCT01781455 is a clinical study titled "A Study of BBI503 in Adult Patients With Advanced Solid Tumors". This is an open label, single arm dose escalation study of BBI503 in adult patients with advanced solid tumors.
What is the current status of trial NCT01781455?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 311 participants. The study started on 2012-02. Estimated completion is 2020-06.
What interventions are being tested in trial NCT01781455?
The interventions under investigation include: BBI503 (DRUG).
Who is sponsoring clinical trial NCT01781455?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01781455's enrollment target sits among peer trials
311 120th of 2000 higher than 1,881 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia